Back to Search
Start Over
[A new antileukemic drug, cytarabine ocfosfate].
- Source :
-
Gan to kagaku ryoho. Cancer & chemotherapy [Gan To Kagaku Ryoho] 1993 Sep; Vol. 20 (12), pp. 1877-83. - Publication Year :
- 1993
-
Abstract
- Cytarabine ocfosfate (commercial name: Starasid) is a prodrug having stearyl group attached to phosphoric acid at 5' position of arabinose moiety of cytosine arabinoside (Ara-C). This drug is given orally. The mode of action is in the inhibition of DNA synthesis after conversion to Ara-CTP as in Ara-C. The drug is metabolized in the liver, producing the intermediate metabolite, C-C3PCA which is converted to Ara-C gradually. This property results in the maintenance of relatively long time the blood Ara-C levels. This was proved to be active clinically against acute leukemia and MDS.
- Subjects :
- Administration, Oral
Animals
Antineoplastic Agents metabolism
Antineoplastic Agents pharmacokinetics
Arabinonucleotides metabolism
Arabinonucleotides pharmacokinetics
Cytidine Monophosphate administration & dosage
Cytidine Monophosphate metabolism
Cytidine Monophosphate pharmacokinetics
Dogs
Female
Humans
Leukemia, Experimental drug therapy
Leukemia, Promyelocytic, Acute pathology
Male
Mice
Rats
Tumor Cells, Cultured
Antineoplastic Agents administration & dosage
Arabinonucleotides administration & dosage
Cytidine Monophosphate analogs & derivatives
Leukemia, Promyelocytic, Acute drug therapy
Prodrugs administration & dosage
Subjects
Details
- Language :
- Japanese
- ISSN :
- 0385-0684
- Volume :
- 20
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- Gan to kagaku ryoho. Cancer & chemotherapy
- Publication Type :
- Academic Journal
- Accession number :
- 8379682